BEAM THERAPEUTICS INC's ticker is BEAM and the CUSIP is 07373V105. A total of 193 filers reported holding BEAM THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| MWG Management Ltd. | 2,346,934 | $74,937,603 | 45.33% |
| HSG Holding Ltd | 796,089 | $25,419,122 | 2.91% |
| Deep Track Capital, LP | 1,317,316 | $42,061,900 | 1.95% |
| Redmile Group, LLC | 1,485,199 | $47,422,404 | 1.82% |
| ARK Investment Management | 8,382,595 | $267,656,246 | 1.77% |
| Casdin Capital, LLC | 570,000 | $18,200,100 | 1.59% |
| Yiheng Capital Management, L.P. | 463,800 | $14,809,134 | 0.80% |
| Temasek Holdings (Private) Ltd | 4,317,789 | $137,867,003 | 0.80% |
| FARALLON CAPITAL MANAGEMENT LLC | 3,441,522 | $109,887,797 | 0.57% |
| Alphabet Inc. | 321,604 | $10,268,815 | 0.55% |
| Capital Impact Advisors, LLC | 12,600 | $402,318 | 0.44% |
| Nikko Asset Management Americas, Inc. | 1,215,080 | $38,797,504 | 0.41% |
| SECTORAL ASSET MANAGEMENT INC | 63,500 | $2,027,555 | 0.34% |
| Bellevue Group AG | 695,421 | $22,204,793 | 0.32% |
| KRAEMATON INVESTMENT ADVISORS, INC | 7,915 | $252,726 | 0.28% |
| Green Alpha Advisors, LLC | 12,491 | $398,838 | 0.26% |
| Eventide Asset Management | 459,203 | $14,662,352 | 0.25% |
| Hood River Capital Management LLC | 251,633 | $8,035,000 | 0.24% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 23,500 | $750,355 | 0.23% |
| Contrarius Investment Management Ltd | 113,364 | $3,620 | 0.20% |
External links
This page lists BEAM THERAPEUTICS INC's shareholders in Q2 2023. To view BEAM THERAPEUTICS INC's shareholder history, click here.